Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Environmental Pollutants and the Risk of Soft Tissue Sarcoma: A Pilot Study

This study has been completed.
Sponsor:
Information provided by:
Memorial Sloan-Kettering Cancer Center
ClinicalTrials.gov Identifier:
NCT00611078
First received: January 25, 2008
Last updated: January 19, 2011
Last verified: January 2011

January 25, 2008
January 19, 2011
September 2004
January 2011   (final data collection date for primary outcome measure)
enrollment of 60 participants [ Time Frame: Conclusion of the study ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00611078 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Environmental Pollutants and the Risk of Soft Tissue Sarcoma: A Pilot Study
Environmental Pollutants and the Risk of Soft Tissue Sarcoma: A Pilot Study

The purpose of this study is to assess the feasibility of conducting a large hospital based case control study of the role of dioxins and dioxinlike polychlorinated dibenzofurans (PCDFs) and polychlorinated biphenyls (PCBs).

Not Provided
Observational
Observational Model: Case Control
Time Perspective: Prospective
Not Provided
Retention:   Samples With DNA
Description:

blood, adipose tissue

Non-Probability Sample

Patients with Soft Tissue Sarcoma at Memorial Sloan Kettering Cancer Center.

Soft Tissue Sarcoma
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
56
January 2011
January 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Patients with Soft tissue sarcoma at MSKCC are eligible for this study if they meet the following criteria:
  • Between 18 and 79 years of age
  • were diagnosed within the previous 6 months with primary soft tissue sarcoma of one of the following histologic subtypes: liposarcoma, leiomyoscaroma, MFH, or synovial sarcoma
  • are enrolled in protocol 02-060 ("Novel Biochemical and Molecularr Determinants for Soft Tissue Sarcoma"; PI, Dr. Samuel Singer)
  • controls will be eligibile for this study if they meet the following criteria
  • are b/w 18-79 years of age
  • have no prior history of cancer (other than non melanoma skin cancer)

Exclusion Criteria:

  • Individuals will be excluded if they
  • are unable to sign informed consent for medical or other reasons
  • do not speak english
Both
18 Years to 79 Years
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00611078
04-088
No
Engel, Lawrence Stuart, PhD, Memorial Sloan-Kettering Cancer Center
Memorial Sloan-Kettering Cancer Center
Not Provided
Principal Investigator: Lawrence Engel, Ph.D. Memorial Sloan-Kettering Cancer Center
Memorial Sloan-Kettering Cancer Center
January 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP